Regulation of in vitro Aβ1-40 aggregation mediated by small molecules

Journal of Alzheimer's Disease

Volumn 22, Issue 1, 2010, Pages 73-85

  Kim, Hye Yun ^a,b   Kim, Youngsoo ^a   Han, Gyoonhee ^b   Kim, Dong Jin ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Alzheimer's disease; amyloid ; fibril; fibrillogenesis; monomer; oligomer; protofibril

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; GLYCINE; HOMOTAURINE; TAURINE; THIOFLAVINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NERVE CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN DETERMINATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 78650634568     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100183     Document Type: Article

References (55)

1. Maslow K (2008) 2008 Alzheimer's disease facts and figures. Alzheimers Dement 4, 110-133.
2. Alzheimer A (1991) A contribution concerning the pathological anatomy of mental disturbances in old age, Alzheimer Dis Assoc Disord 5, 69-70.
3. Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
4. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100, 330-335.
5. Jan A, Gokce O, Luthi-Carter R, Lashuel HA (2008) The ratio of monomeric to aggregated forms of Abeta40 and Abe-ta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem 283, 28176-28189.
6. Kim Y, Lee JH, Ryu J, Kim DJ (2009) Multivalent & multifunctional ligands to beta-amyloid. Curr Pharm Des 15, 637658.
7. Claudio Soto, Martin Z (2009) Therapeutic strategies against protein misfolding in neurodegenerative diseases. Expert Opin Drug Discov 4, 71-84.
8. Xu Y, Shen J, Luo X, Zhu W, Chen K, Ma J, Jiang H (2005) Conformational transition of amyloid beta-peptide. Proc Natl Acad Sci USA 102, 5403-5407.
9. Lazo ND, Grant MA, Condron MC, Rigby AC, Teplow DB (2005) On the nucleation of amyloid beta-protein monomer folding. Protein Sci 14, 1581-1596.
10. Barrow CJ, Zagorski MG (1991) Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-182.
11. Finder VH, Glockshuber R (2007) Amyloid-beta aggregation. Neurodegener Dis 4, 13-27.
12. Reed MN, Hofmeister JJ, Jungbauer L, Welzel AT, Yu C, Sherman MA, Lesne S, Ladu MJ, Walsh DM, Ashe KH, Cleary JP (2009) Cognitive effects of cell-derived and synthetically derived Abeta oligomers. Neurobiol Aging, (in press).
13. Schmechel A, Zentgraf H, Scheuermann S, Fritz G, Pipko-rn R, Reed J, Beyreuther K, Bayer TA, Multhaup G (2003) Alzheimer beta-amyloid homodimers facilitate A beta fibril-lization and the generation of conformational antibodies. J Biol Chem 278, 35317-35324.
14. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R (2005) Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307, 262265.
15. Ye L, Morgenstern JL, Lamb JR, Lockhart A (2006) Characterisation of the binding of amyloid imaging tracers to rodent Abeta fibrils and rodent-human Abeta co-polymers. Biochem Biophys Res Commun 347, 669-677.
16. Liu Y, Dargusch R, Maher P, Schubert D (2008) A broadly neuroprotective derivative of curcumin. J Neurochem 105, 1336-1345.
17. Reinke AA, Gestwicki JE (2007) Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des 70, 206-215.
18. Okada T, Wakabayashi M, Ikeda K, Matsuzaki K (2007) Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J Mol Biol 371, 481-489.
19. Liu D, Xu Y, Feng Y, Liu H, Shen X, Chen K, Ma J, Jiang H (2006) Inhibitor discovery targeting the intermediate structure ofbeta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism ofbeta-amyloid peptide. Biochemistry 45, 10963-10972.
20. Good NE, Winget GD, Winter W, Connolly TN, Izawa S, Singh RM (1966) Hydrogen ion buffers for biological research. Biochemistry 5, 467-477.
21. Gervais F, Paquette J, Morissette C, Krzywkowski P, Yu M, Azzi M, Lacombe D, Kong X, Aman A, Laurin J, Szarek WA, Tremblay P (2007) Targeting soluble Abeta peptide with Tramiprosate forthe treatment of brain amyloidosis. Neurobiol Aging 28, 537-547.
22. Santa-Maria I, Hernandez F, Del Rio J, Moreno FJ, Avila J (2007) Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau. Mol Neurodegener 2, 17.
23. Santa-Maria I, Hernandez F, Moreno FJ, Avila J (2007) Tau-rine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation. Neurosci Lett 429, 91-94.
24. Cellamare S, Stefanachi A, Stolfa DA, Basile T, Catto M, Cam-pagna F, Sotelo E, Acquafredda P, Carotti A (2008) Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Abeta1-40 aggregation in vitro. Bioorg Med Chem 16, 4810-4822.
25. Harmeier A, Wozny C, Rost BR, Munter LM, Hua H, Georgiev O, Beyermann M, Hildebrand PW, Weise C, Schaffner W, Schmitz D, Multhaup G (2009) Role of amyloid-beta glycine 33 in oligomerization, toxicity, and neuronal plasticity. JNeu-rosci 29, 7582-7590.
26. Kim YS, Moss JA, Janda KD (2004) Biological tuning of synthetic tactics in solid-phase synthesis: application to A beta(1-42). J Org Chem 69, 7776-7778.
27. Kim DJ, Kim HY, Kim Y (2008) Methods for the formation of beta-amyloid oligomer and for screening of materials having an inhibition activity in the aggregation of beta-amyloid. (Korea) KR 1020080083877.
28. Rahimi F, Maiti P, Bitan G (2009) Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides. J Vis Exp.
29. LeVine H, 3rd (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2, 404-410.
30. Levine H, 3rd (1995) Thioflavine T interaction with amyloid beta-sheet structures. Amyloid 2, 1-6.
31. Byun JH, Kim H, Kim Y, Mook-Jung I, Kim DJ, Lee WK, Yoo KH (2008) Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation. Bioorg Med Chem Lett 18, 5591-5593.
32. Hasegawa K, Yamaguchi I, Omata S, Gejyo F, Naiki H (1999) Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 38, 15514-15521.
33. Fancy DA, Kodadek T (1999) Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc Natl Acad Sci U S A 96, 6020-6024.
34. Bitan G, Lomakin A, Teplow DB (2001) Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking ofunmodified proteins. J Biol Chem 276, 35176-35184.
35. Bitan G, Teplow DB (2004) Rapid photochemical cross-linking-a new tool for studies of metastable, amyloidogenic protein assemblies. Acc Chem Res 37, 357-364.
36. Harris JR (2002) In vitro fibrillogenesis of the amyloid beta 42 peptide: cholesterol potentiation and aspirin inhibition. Micron 33, 609-626.
37. Patel D, Good T (2007) A rapid method to measure beta-amyloid induced neurotoxicity in vitro. J Neurosci Methods 161, 1-10.
38. Gursoy E, Cardounel A, Kalimi M (2001) Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. Neurochem Res 26, 15-21.
39. He W, Barrow CJ (1999) The A beta 3-pyroglutamyl and pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta. Biochemistry 38, 10871-10877.
40. Lynn DG, Meredith SC (2000) Review: model peptides and the physicochemical approach to beta-amyloids. J Struct Biol 130, 153-173.
41. Valerio M, Porcelli F, Zbilut JP, Giuliani A, Manetti C, Conti F (2008) pH effects on the conformational preferences of amyloid beta-peptide (1-40) in HFIP aqueous solution by NMR spectroscopy. ChemMedChem 3, 833-843.
42. Vollers SS, Teplow DB, Bitan G (2005) Determination of Peptide oligomerization state using rapid photochemical crosslinking. Methods Mol Biol 299, 11-18.
43. LashuelHA, Grillo-BoschD(2005) Invitro preparation of pre-fibrillar intermediates of amyloid-beta and alpha-synuclein. Methods Mol Biol 299, 19-33.
44. Aslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konrads-son P, Holtzman DM, Hof PR, Heppner FL, Gandy S, Juck-er M, Aguzzi A, Hammarstrom P, Nilsson KP (2009) Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 4, 673-684.
45. Haass C, Steiner H (2001) Protofibrils, the unifying toxic molecule of neurodegenerative disorders? Nat Neurosci 4, 859-860.
46. Moss MA, Nichols MR, Reed DK, Hoh JH, Rosenber-ry TL (2003) The peptide KLVFF-K(6) promotes beta-amyloid(1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Mol Pharmacol 64, 1160-1168.
47. Englund H, Sehlin D, Johansson AS, Nilsson LN, Gellerfors P, Paulie S, Lannfelt L, Pettersson FE (2007) Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. J Neurochem 103, 334-345.
48. Wright TM (2006) Tramiprosate. Drugs Today (Barc) 42, 291-298.
49. Bartolini M, Bertucci C, Cavrini V, Andrisano V (2003) beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 65, 407-416.
50. Di Carlo M (2010) Beta amyloid peptide: from different aggregation forms to the activation of different biochemical pathways. Eur Biophys J 39, 877-888.
51. Lim KH, Kim YK, Chang YT (2007) Investigations of the molecular mechanism of metal-induced Abeta (1-40) amy-loidogenesis. Biochemistry 46, 13523-13532.
52. Klement K, Wieligmann K, Meinhardt J, Hortschansky P, Richter W, Fandrich M (2007) Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's abeta(1-40) amyloid fibrils. J Mol Biol 373, 1321-1333.
53. Pirlich M, Kiok K, Sandig G, Lochs H, Grune T (2002) Alpha-lipoic acid prevents ethanol-induced protein oxidation in mouse hippocampal HT22 cells. Neurosci Lett 328, 93-96.
54. Castillo GM, Lukito W, Wight TN, Snow AD (1999) The sul-fate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J Neu-rochem 72, 1681-1687.
55. Sachse C, Fandrich M, Grigorieff N (2008) Paired beta-sheet structure of an Abeta(1-40) amyloid fibril revealed by electron microscopy. Proc Natl Acad Sci USA 105, 7462-7466.